Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryoji Hanada

Showing results (61-70 of 86) with videos related to

Pageof 9
Sort By:
International Journal of Hematology|April 22, 2011
Case series of pediatric acute leukemia without a peripheral blood abnormality, detected by magnetic resonance imagingMotohiro Kato, Katsuyoshi Koh, Akira Kikuchi, et al.
International Journal of Oncology|September 10, 2003
Aberrations of p16INK4A, p14ARF and p15INK4B genes in pediatric solid tumorsKazuko Obana, Hong-Wei Yang, Hui-Ying Piao, et al.
Pediatric Blood & Cancer|April 30, 2019
A case of malignant rhabdoid tumor mimicking yolk sac tumorYasuo Kubota, Yuki Arakawa, Masahiro Sekiguchi, et al.
British Journal of Haematology|October 11, 2011
DNMT3A mutations are rare in childhood acute myeloid leukaemia, myelodysplastic syndromes and juvenile myelomonocytic leukaemiaNorio Shiba, Tomohiko Taki, Myoung-Ja Park, et al.
Cancer Science|April 13, 2013
Characterization of genetic lesions in rhabdomyosarcoma using a high-density single nucleotide polymorphism arrayRiki Nishimura, Junko Takita, Aiko Sato-Otsubo, et al.
Leukemia & Lymphoma|October 19, 2017
A pediatric case of acute megakaryocytic leukemia with double chimeric transcripts of CBFA2T3-GLIS2 and DHH-RHEBL1Kanako Mitsui-Sekinaka, Yujin Sekinaka, Yumi Ogura, et al.
International Journal of Hematology|March 13, 2012
RAS mutations are frequent in FAB type M4 and M5 of acute myeloid leukemia, and related to late relapse: a study of the Japanese Childhood AML Cooperative Study GroupHirozumi Sano, Akira Shimada, Tomohiko Taki, et al.
British Journal of Haematology|August 26, 2010
Prospective study of a therapeutic regimen with all-trans retinoic acid and anthracyclines in combination of cytarabine in children with acute promyelocytic leukaemia: the Japanese childhood acute myeloid leukaemia cooperative studyMasue Imaizumi, Akio Tawa, Ryoji Hanada, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2007
Prospective study of a pirarubicin, intermediate-dose cytarabine, and etoposide regimen in children with Down syndrome and acute myeloid leukemia: the Japanese Childhood AML Cooperative Study GroupKazuko Kudo, Seiji Kojima, Ken Tabuchi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2009
Risk-stratified therapy and the intensive use of cytarabine improves the outcome in childhood acute myeloid leukemia: the AML99 trial from the Japanese Childhood AML Cooperative Study GroupIchiro Tsukimoto, Akio Tawa, Keizo Horibe, et al.
Pageof 9

Showing results (61-70 of 86) with videos related to

Sort By:
Pageof 9
International Journal of Hematology|April 22, 2011
Case series of pediatric acute leukemia without a peripheral blood abnormality, detected by magnetic resonance imagingMotohiro Kato, Katsuyoshi Koh, Akira Kikuchi, et al.
International Journal of Oncology|September 10, 2003
Aberrations of p16INK4A, p14ARF and p15INK4B genes in pediatric solid tumorsKazuko Obana, Hong-Wei Yang, Hui-Ying Piao, et al.
Pediatric Blood & Cancer|April 30, 2019
A case of malignant rhabdoid tumor mimicking yolk sac tumorYasuo Kubota, Yuki Arakawa, Masahiro Sekiguchi, et al.
British Journal of Haematology|October 11, 2011
DNMT3A mutations are rare in childhood acute myeloid leukaemia, myelodysplastic syndromes and juvenile myelomonocytic leukaemiaNorio Shiba, Tomohiko Taki, Myoung-Ja Park, et al.
Cancer Science|April 13, 2013
Characterization of genetic lesions in rhabdomyosarcoma using a high-density single nucleotide polymorphism arrayRiki Nishimura, Junko Takita, Aiko Sato-Otsubo, et al.
Leukemia & Lymphoma|October 19, 2017
A pediatric case of acute megakaryocytic leukemia with double chimeric transcripts of CBFA2T3-GLIS2 and DHH-RHEBL1Kanako Mitsui-Sekinaka, Yujin Sekinaka, Yumi Ogura, et al.
International Journal of Hematology|March 13, 2012
RAS mutations are frequent in FAB type M4 and M5 of acute myeloid leukemia, and related to late relapse: a study of the Japanese Childhood AML Cooperative Study GroupHirozumi Sano, Akira Shimada, Tomohiko Taki, et al.
British Journal of Haematology|August 26, 2010
Prospective study of a therapeutic regimen with all-trans retinoic acid and anthracyclines in combination of cytarabine in children with acute promyelocytic leukaemia: the Japanese childhood acute myeloid leukaemia cooperative studyMasue Imaizumi, Akio Tawa, Ryoji Hanada, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2007
Prospective study of a pirarubicin, intermediate-dose cytarabine, and etoposide regimen in children with Down syndrome and acute myeloid leukemia: the Japanese Childhood AML Cooperative Study GroupKazuko Kudo, Seiji Kojima, Ken Tabuchi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2009
Risk-stratified therapy and the intensive use of cytarabine improves the outcome in childhood acute myeloid leukemia: the AML99 trial from the Japanese Childhood AML Cooperative Study GroupIchiro Tsukimoto, Akio Tawa, Keizo Horibe, et al.
Pageof 9